🔗 Share this article

Given that America undertakes sweeping revisions to its vaccine schedules, one figure has emerged in a surprising turn: Høeg, an American of Danish descent sports medicine doctor and epidemiologist who rose to prominence by questioning COVID-19 vaccines in the pandemic and has concentrated on potential deaths after Covid immunization in her brief position at the Food and Drug Administration.

Proposed Changes to Pediatric Vaccine Schedule

Health officials had intended to unveil sweeping revisions to the pediatric immunization program earlier this month, bringing the US with the Danish vaccine program, according to reports – a major change that would place the US at odds with many the global community with insufficient data for benefit. The announcement has been delayed until the next year.

In place of the director of the vaccine center, Høeg is listed to speak at the gathering. She was just designated acting director of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to head the division this year.

A New Direction at the FDA

Høeg's temporary position could signify a strengthened alliance between the pharmaceutical and vaccine centers as Dr. Høeg and Dr. Prasad consolidate power at the FDA – and it suggests a renewed priority upon dismantling previously authorized vaccines at the FDA.

Dr. Høeg has frequently advocated for halting some pediatric immunization guidelines in the US so as to align more similar to Denmark, a society with nationalized medicine and a population roughly the size of the state of Wisconsin.

So far public appearances, she has continued to focus on vaccination policy – typically the purview of Prasad, head of the FDA’s vaccine center – as opposed to medication approval.

Questions Over Background

Dr. Høeg has no apparent background in drug development, regulation or administrative roles, which has been standard for previous heads of the biologics center. She has been employed at the FDA as a senior adviser to the commissioner and CBER since earlier this year.

“She appears not to have the requisite experience” for leading the CDER, stated a neurologist and psychiatrist. “She has not conducted a scientific study. She is not versed in managing a sizeable institution. She is not an expert in pharmaceutical oversight.”

Previous heads of the center would “grasp laws and regulations and the research of drug development”, said a former acting FDA commissioner. “Clearly, she doesn’t have the sort of resume that former directors who headed CBER have had.”

The drug center has an enormous range of responsibilities at the FDA, the former commissioner pointed out.

“Everybody just pays attention on the innovative therapies, but the off-patent medication office clears a multitude of generic medications. There is also a biologic copycat branch, OTC medication office and other areas, and every single one must be supervised,” she explained. “The responsibility you don’t keep your eye on, that is precisely what that I always told people is going to come back to haunt you.”

Additionally, a substantial management component to the role, which supervises over 5,000 personnel. “It is a enormous management job, if you execute it properly,” Woodcock added.

Official Statement and Contentious Programs

Regarding inquiries about Dr. Høeg's qualifications and whether this appointment represents increased cooperation among agency officials on immunizations, a spokesperson responded that the “concerns are based on inaccurate presumptions”.

“Her experience matches the functions of her role,” the representative explained, pointing to the period Høeg spent advising the FDA commissioner on “pharmaceutical safety and approval science, including predictive safety algorithms and vaccine surveillance”.

As acting director, Høeg inherits the commissioner’s recently launched expedited review system, a controversial one-day drug-approval program that reportedly worried her former heads. “By what process are these therapies being picked for this voucher program? Who takes the choices?” Dr. Howard questioned. “There’s a lot of lack of transparency occurring at the agency right now.”

Overall, he stated, “the Food and Drug Administration looks to be trending towards laxer oversight of most medications, except for shots.”

Public Past Work on Immunizations

Regarding vaccines, Høeg has a more documented, if problematic, past, critics observe. She published a analysis using non-validated crowd-sourced reports to assess the rate of heart inflammation following COVID-19 vaccination. She consulted for the state of Florida top health official Joseph Ladapo, who reportedly have changed statistics to suggest COVID-19 vaccinations are pose a greater threat than they are.

Among her “wish list” for the current administration encompassed changing rules for recently developed shots and ending “unnecessary” immunizations, she said following the vote on a podcast. At the agency, Dr. Høeg has allegedly proposed barring young men from getting COVID-19 vaccinations.

“She’s an complete ideologue who starts off with her beliefs and works backwards to retrofit the science in a very misleading, untruthful way,” Howard stated.

Consolidating Power and a “Revenge Tour”

Høeg became part of other skeptics, {like|